Systematic review of drug bioavailability following gastrointestinal surgery

[1]  R. Kim,et al.  Personalized Anticoagulation: Guided Apixaban Dose Adjustment to Compensate for Pharmacokinetic Abnormalities Related to Short-Bowel Syndrome. , 2017, The Canadian journal of cardiology.

[2]  S. Middeldorp,et al.  Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: The PDER PAN study. , 2017, Thrombosis research.

[3]  M. Clark,et al.  Comparison of Bioavailability of Single‐Dose Extended‐Release Venlafaxine Capsules in Obese Patients Before and After Gastric Bypass Surgery , 2017, Pharmacotherapy.

[4]  G. D'offizi,et al.  Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro‐resected patient , 2017, Journal of clinical pharmacy and therapeutics.

[5]  A. Dahan,et al.  Impaired oral absorption of methylphenidate after Roux-en-Y gastric bypass. , 2017, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[6]  L. Alberio,et al.  Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery , 2017, British journal of clinical pharmacology.

[7]  U. Christians,et al.  Pharmacokinetic and pharmacogenetic analysis of immunosuppressive agents after laparoscopic sleeve gastrectomy , 2017, Clinical transplantation.

[8]  K. Langohr,et al.  Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism , 2017, Obesity Surgery.

[9]  S. Weber,et al.  Cure with ledipasvir/sofosbuvir for chronic hepatitis C virus in an individual with gastric bypass , 2017, Journal of clinical pharmacy and therapeutics.

[10]  J. S. Santos,et al.  Omeprazole Absorption and Fasting Gastrinemia After Roux-en-Y Gastric Bypass , 2017, Obesity Surgery.

[11]  D. Murawa,et al.  The pharmacokinetics of oral ketoprofen in patients after gastric resection. , 2017, Pharmacological reports : PR.

[12]  S. Czernichow,et al.  Tenofovir pharmacokinetic after sleeve-gastrectomy in four severely obese patients living with HIV. , 2017, Obesity research & clinical practice.

[13]  W. Sugiura,et al.  Therapeutic Drug Monitoring of Anti-human Immunodeficiency Virus Drugs in a Patient with Short Bowel Syndrome , 2016, Internal medicine.

[14]  O. Spigset,et al.  Bioavailability of Methadone After Sleeve Gastrectomy: A Planned Case Observation. , 2016, Clinical therapeutics.

[15]  J. Nykiel,et al.  Lithium toxicity after Roux-en-Y bariatric surgery , 2016, BMJ Case Reports.

[16]  R. V. van Schaik,et al.  The Effect of Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients on Pharmacokinetics of (Acetyl)Salicylic Acid and Omeprazole: the ERY-PAO Study , 2016, Obesity Surgery.

[17]  S. Benvenga,et al.  TSH Normalization in Bariatric Surgery Patients After the Switch from l-Thyroxine in Tablet to an Oral Liquid Formulation , 2016, Obesity Surgery.

[18]  C. Matthys,et al.  Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations. , 2015, British journal of clinical pharmacology.

[19]  M. Gawaz,et al.  Individualised dual antiplatelet therapy in a patient with short bowel syndrome after acute myocardial infarction with coronary artery stenting , 2015, BMJ Case Reports.

[20]  D. Flum,et al.  Proximal Roux‐en‐Y Gastric Bypass Alters Drug Absorption Pattern But Not Systemic Exposure of CYP3A4 and P‐glycoprotein Substrates , 2015, Pharmacotherapy.

[21]  O. Corcos,et al.  Antidepressant agents in short bowel syndrome. , 2014, Clinical therapeutics.

[22]  D. Murawa,et al.  The pharmacokinetics of oral oxycodone in patients after total gastric resection. , 2014, European review for medical and pharmacological sciences.

[23]  J. Stein,et al.  Review article: the nutritional and pharmacological consequences of obesity surgery , 2014, Alimentary pharmacology & therapeutics.

[24]  J. Oppert,et al.  Effect of a Roux-en-Y Gastric Bypass on the Pharmacokinetics of Oral Morphine Using a Population Approach , 2014, Clinical Pharmacokinetics.

[25]  G. Demetri,et al.  Effect of gastrointestinal resection on sunitinib exposure in patients with GIST , 2014, BMC Cancer.

[26]  E. de Raucourt,et al.  Absorption and Efficacy of Acetylsalicylic Acid in Patients With Short Bowel Syndrome , 2014, The Annals of pharmacotherapy.

[27]  J. Kiser,et al.  Tenofovir, Emtricitabine, and Darunavir/Ritonavir Pharmacokinetics in an HIV-Infected Patient After Roux-en-Y Gastric Bypass Surgery , 2014, The Annals of pharmacotherapy.

[28]  D. Murawa,et al.  The pharmacokinetics of the effervescent vs. conventional tramadol/paracetamol fixed-dose combination tablet in patients after total gastric resection , 2014, Pharmacological reports : PR.

[29]  K. Sakhaee,et al.  Superior calcium bioavailability of effervescent potassium calcium citrate over tablet formulation of calcium citrate after Roux-en-Y gastric bypass. , 2013, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[30]  James E Mitchell,et al.  A Comparison of Duloxetine Plasma Levels in Postbariatric Surgery Patients Versus Matched Nonsurgical Control Subjects , 2013, Journal of clinical psychopharmacology.

[31]  A. Kastenmeier,et al.  Consequences of gastrointestinal surgery on drug absorption. , 2013, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[32]  C. Cappelli,et al.  Oral Liquid l-Thyroxine (l-T4) May Be Better Absorbed Compared to l-T4 Tablets Following Bariatric Surgery , 2013, Obesity Surgery.

[33]  K. Markou,et al.  Improved levothyroxine pharmacokinetics after bariatric surgery. , 2013, Thyroid : official journal of the American Thyroid Association.

[34]  M. Pai,et al.  Oral bioavailability of linezolid before and after Roux-en-Y gastric bypass surgery: is dose modification necessary in obese subjects? , 2013, The Journal of antimicrobial chemotherapy.

[35]  B. Wilffert,et al.  Influence of Bariatric Surgery on the Use and Pharmacokinetics of Some Major Drug Classes , 2013, Obesity Surgery.

[36]  J. Beyer-Westendorf,et al.  Pharmacokinetics of rivaroxaban after bariatric surgery: a case report , 2013, Journal of Thrombosis and Thrombolysis.

[37]  A. Åsberg,et al.  Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin , 2012, Surgical Endoscopy.

[38]  D. Ashcroft,et al.  Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes. , 2012, British journal of clinical pharmacology.

[39]  Arya M. Sharma,et al.  Effect of gastric bypass surgery on azithromycin oral bioavailability. , 2012, The Journal of antimicrobial chemotherapy.

[40]  M. H. Ensom,et al.  Pharmacokinetic Effects of Bariatric Surgery , 2012, The Annals of pharmacotherapy.

[41]  James E Mitchell,et al.  Preliminary comparison of sertraline levels in postbariatric surgery patients versus matched nonsurgical cohort. , 2012, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[42]  L. V. Van Bortel,et al.  Oral bioavailability of moxifloxacin after Roux-en-Y gastric bypass surgery. , 2012, The Journal of antimicrobial chemotherapy.

[43]  M. Santo,et al.  Levothyroxine Absorption in Morbidly Obese Patients Before and After Roux-En-Y Gastric Bypass (RYGB) Surgery , 2012, Obesity Surgery.

[44]  B. Henriksen,et al.  Pharmacokinetic considerations in Roux-en-Y gastric bypass patients. , 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[45]  Arya M. Sharma,et al.  Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of Metformin , 2011, Diabetes Care.

[46]  D. Pournaras,et al.  Reduced Phenytoin Levels in an Epileptic Patient following Roux-En-Y Gastric Bypass for Obesity , 2011, Obesity surgery.

[47]  K. Stormark,et al.  Significant Increase in Systemic Exposure of Atorvastatin After Biliopancreatic Diversion With Duodenal Switch , 2010, Clinical pharmacology and therapeutics.

[48]  Tae Won Kim,et al.  Cross-sectional study of imatinib plasma trough levels in patients with advanced gastrointestinal stromal tumors: impact of gastrointestinal resection on exposure to imatinib. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  D. Brocks,et al.  A systematic review of drug absorption following bariatric surgery and its theoretical implications , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[50]  Nicola Ward.  The Impact of Intestinal Failure on Oral Drug Absorption: A Review , 2010, Journal of Gastrointestinal Surgery.

[51]  M. Egorin,et al.  Imatinib Mesylate Pharmacokinetics Before and After Sleeve Gastrectomy in a Morbidly Obese Patient with Chronic Myeloid Leukemia , 2009, Pharmacotherapy.

[52]  K. Stormark,et al.  Significantly Altered Systemic Exposure to Atorvastatin Acid Following Gastric Bypass Surgery in Morbidly Obese Patients , 2009, Clinical pharmacology and therapeutics.

[53]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions : Explanation and Elaboration , 2009 .

[54]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[55]  B. Adams-Huet,et al.  Comparison of the Absorption of Calcium Carbonate and Calcium Citrate after Roux-en-Y Gastric Bypass , 2009, Obesity surgery.

[56]  S. Oka,et al.  Successful absorption of antiretroviral drugs after gastrojejunal bypass surgery following failure of therapy through a jejunal tube. , 2009, Internal medicine.

[57]  Deric M. Park,et al.  Disposition of temozolomide in a patient with glioblastoma multiforme after gastric bypass surgery , 2009, Journal of Neuro-Oncology.

[58]  O. Kirton,et al.  Warfarin Resistance After Total Gastrectomy and Roux‐en‐Y Esophagojejunostomy , 2008, Pharmacotherapy.

[59]  José Wander Breganó,et al.  Comparison of ferrous sulfate and ferrous glycinate chelate for the treatment of iron deficiency anemia in gastrectomized patients. , 2008, Nutrition.

[60]  J. Alexander,et al.  Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end‐stage renal disease and transplant patients: a pilot study , 2007, Clinical transplantation.

[61]  Yolima Baena,et al.  Importancia y fundamentación del sistema de clasificación biofarmacéutico, como base de la exención de estudios de biodisponibilidad y bioequivalencia in vivo , 2008 .

[62]  S. Shapses,et al.  True Fractional Calcium Absorption is Decreased After Roux‐En‐Y Gastric Bypass Surgery , 2006, Obesity.

[63]  April D. Miller,et al.  Medication and nutrient administration considerations after bariatric surgery. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[64]  M. Egorin,et al.  Disposition of Imatinib and Its Metabolite CGP74588 in a Patient with Chronic Myelogenous Leukemia and Short‐Bowel Syndrome , 2006, Pharmacotherapy.

[65]  A. Jain,et al.  Change in oral absorption of tacrolimus in a liver transplant recipient after reversal of jejunoileal bypass: case report. , 2005, Transplantation proceedings.

[66]  D. Greenblatt,et al.  Absorption of oral tetracycline in patients with Billroth-II gastrectomy , 1978, Journal of Pharmacokinetics and Biopharmaceutics.

[67]  G. Bongaerts,et al.  Enteral Drug Absorption in Patients with Short Small Bowel , 2004, Clinical pharmacokinetics.

[68]  L. Prescott,et al.  Absorption of penicillin and paracetamol after small intestinal bypass surgery , 2004, European Journal of Clinical Pharmacology.

[69]  S. Rayhill,et al.  Dose-Adjusted Cyclosporine C2 in a Patient with Jejunoileal Bypass as Compared to Seven Other Liver Transplant Recipients , 2003, Therapeutic drug monitoring.

[70]  L. Bauer,et al.  Applied Clinical Pharmacokinetics , 2001 .

[71]  Leigh-Ann Topfer,et al.  Etext on Health Technology Assessment (HTA) Information Resources , 2000 .

[72]  R. Löbenberg,et al.  Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards , 2000 .

[73]  M. Droździk,et al.  Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative study , 2000, European Journal of Clinical Pharmacology.

[74]  M. Rela,et al.  Oral absorption of tacrolimus in children with intestinal failure due to short or absent small bowel , 1999, Transplant international : official journal of the European Society for Organ Transplantation.

[75]  B. Robbins,et al.  Amitriptyline absorption in a patient with short bowel syndrome. , 1999 .

[76]  B. Robbins,et al.  Amitriptyline absorption in a patient with short bowel syndrome , 1999, American Journal of Gastroenterology.

[77]  Y. Hamanaka,et al.  Serum drug concentrations after oral administration of paracetamol to patients with surgical resection of the gastrointestinal tract. , 1995, British journal of clinical pharmacology.

[78]  Stephanie E. Guerriero,et al.  Malabsorption of Digoxin Tablets, Gel Caps, and Elixir in a Patient with an End Jejunostomy , 1994, The Annals of pharmacotherapy.

[79]  P. Gubbins,et al.  Drug Absorption in Gastrointestinal Disease and Surgery , 1991, Clinical pharmacokinetics.

[80]  J. Bengoa,et al.  Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection. , 1991, The American journal of clinical nutrition.

[81]  T. Self,et al.  Nortriptyline absorption in short bowel syndrome. , 1990, JPEN. Journal of parenteral and enteral nutrition.

[82]  I. Sketris,et al.  Cyclosporine Absorption in Two Patients with Short-Bowel Syndrome , 1988, Drug intelligence & clinical pharmacy.

[83]  D. Back,et al.  The bioavailability of ethinyloestradiol and levonorgestrel in patients with an ileostomy. , 1986, Contraception.

[84]  O. Fausa,et al.  Pharmacokinetics of metronidazole in patients with enteric disease compared to normal volunteers. , 1981, Chemotherapy.

[85]  M. Kennedy,et al.  Phenytoin absorption in patients with ileojejunal bypass. , 1979, British journal of clinical pharmacology.

[86]  Tore Talseth,et al.  Clinical Pharmacokinetics of Hydralazine , 1977 .

[87]  C. Zukoski,et al.  The Effect of Jejunoileal Bypass on the Pharmacokinetics of Digoxin in Man , 1977, Circulation.